Workflow
CSX(CSX)
icon
Search documents
3 Unpopular Stocks That Concern Us
Yahoo Finance· 2025-11-07 04:37
Group 1: Market Sentiment - Wall Street's bearish price targets for certain stocks indicate serious concerns within the industry, which is unusual given the tendency to prioritize corporate relationships over transparency [1] - The article highlights three stocks with warranted bearish outlooks and suggests alternatives with better fundamentals [1] Group 2: Dillard's (DDS) - Dillard's has a consensus price target of $381.67, implying a -36.5% return from its current trading price of $600.94 per share, which reflects a forward P/E ratio of 21.9x [2][4] - Concerns about Dillard's include weak demand indicated by the absence of new stores, lagging same-store sales, and a projected sales decline of 1% over the next 12 months [10] Group 3: CSX (CSX) - CSX has a consensus price target of $39.29, suggesting an 11.7% implied return, while its current stock price is $35.18, reflecting a forward P/E ratio of 19x [5][7] - The article suggests that CSX does not meet investment criteria, although specific reasons are not detailed in the provided text [6] Group 4: Dell (DELL) - Dell's consensus price target is $164.09, indicating a 9.5% implied return [8] - Concerns regarding Dell include underwhelming unit sales, a decrease in earnings per share relative to revenue, and a significant reduction in free cash flow margin by 18.9 percentage points over the last five years [11]
CSX Executive Vice President and Chief Financial Officer to Address Baird Global Industrial Conference
Globenewswire· 2025-11-04 14:00
Core Insights - CSX Corp. will be represented by Executive Vice President and CFO Kevin Boone at the 2025 Baird Global Industrial Conference on November 11, 2025 [1] - The event will be available for live streaming and a replay will be accessible afterward [2] Company Overview - CSX is a leading transportation company based in Jacksonville, Florida, providing rail, intermodal, and rail-to-truck transload services across various markets including energy, industrial, construction, agricultural, and consumer products [3] - The company has been integral to the economic expansion and industrial development of the United States for nearly 200 years, connecting major metropolitan areas in the eastern U.S. where about two-thirds of the nation's population resides [3] - CSX's network links over 240 short-line railroads and more than 70 ocean, river, and lake ports with significant population centers and farming communities [3]
CSX Stock: Analyst Estimates & Ratings
Yahoo Finance· 2025-11-03 09:21
Core Insights - CSX Corporation, with a market cap of $67.1 billion, is a leading freight railroad company in the U.S., providing rail-based transportation services for various goods [1] Financial Performance - CSX stock has gained 7.4% over the past year and 11.6% year-to-date, underperforming the S&P 500 Index, which surged 17.7% over the same period [2] - The company reported third-quarter earnings with an adjusted EPS of $0.44, exceeding expectations, but revenue of $3.59 billion slightly missed estimates [4] - Analysts forecast CSX to report an EPS of $1.65 for the current year, reflecting a 9.8% decline from the prior year [5] Analyst Ratings - The stock has a consensus "Moderate Buy" rating, with 17 "Strong Buys," 2 "Moderate Buys," and 7 "Holds" among 26 analysts [5] - J.P. Morgan analyst Brian Ossenbeck reiterated a "Buy" rating with a price target of $40, while the mean price target of $38.96 suggests an 8.2% upside from current levels [6]
Insiders Are Snapping Up These 2 Stocks — and Analysts Like What They See
Yahoo Finance· 2025-10-31 11:07
Company Overview - Summit Therapeutics is a biopharma company focused on developing ivonescimab, a novel therapeutic agent for non-small cell lung cancer (NSCLC) [3] - The company has exclusive rights to develop and commercialize ivonescimab in the US, Canada, Europe, and Japan under a license agreement with Akeso [3] Clinical Trials and Drug Development - Summit is conducting multiple clinical trials for ivonescimab, including HARMONi, HARMONi-3, and HARMONi-7, targeting various NSCLC treatment lines [1][8] - A new Phase 3 trial, HARMONi-GI3, is set to begin, focusing on colorectal cancer with an enrollment of approximately 600 patients [1] - Positive results from the HARMONi trial have led to plans for a Biologics License Application to the FDA in 4Q25 [8] Financial Insights and Insider Activity - Recent insider purchases include Co-CEOs Maky Zanganeh and Robert Duggan buying 26,680 shares each, and Board member Xia Yu purchasing 533,617 shares for nearly $10 million [9] - Analysts view Summit's stock as attractively valued, with a Moderate Buy consensus rating based on 14 reviews, including 10 Buy ratings [11] Analyst Perspectives - Analysts highlight ivonescimab's efficacy across various NSCLC subgroups, emphasizing its versatility and potential superiority over existing treatments [10] - The stock is currently priced at $18.66, with an average price target of $30.92, suggesting a potential one-year gain of 66% [11]
CFOs On the Move: Week ending Oct. 31
Yahoo Finance· 2025-10-31 09:53
Leadership Changes - Adam Elinoff appointed as CFO of Agilent Technologies effective Nov. 17, previously held leadership roles at Amgen for 19 years [2] - Paul Todd named new CFO of Fiserv effective Oct. 31, previously CFO at Global Payments and spent over 11 years at TSYS [3] - Kevin Boone appointed as executive vice president and CFO of CSX, previously served as CFO from 2019 to 2021 [4] - Paul Kuehneman named interim CFO and controller of Hormel Foods, has been with the company since 1993 [5] Company Backgrounds - Agilent Technologies specializes in scientific instruments, with Elinoff succeeding interim CFO Rodney Gonsalves [2] - Fiserv is a payments firm that recently missed earnings forecasts and cut its outlook, leading to leadership changes [3] - CSX is a railroad operator, with Boone having a background in finance, accounting, and M&A [4] - Hormel Foods is a food company, with Kuehneman having extensive experience within the organization [5]
CSX appoints Boone as CFO, Kenney as CCO
Yahoo Finance· 2025-10-30 12:41
Core Insights - CSX announced executive leadership changes to enhance strategic focus and support long-term growth objectives [1] Leadership Changes - Kevin Boone has been appointed as executive vice president and chief financial officer (CFO), succeeding Sean Pelkey, who has left the company [1] - Maryclare Kenney has been promoted to senior vice president and chief commercial officer (CCO), emphasizing the company's commitment to value creation and momentum [1]
Rail volumes down 3%: what it means for 2025
Yahoo Finance· 2025-10-29 17:29
Industry Overview - U.S. Class I railroads are experiencing tepid growth with a 3% year-over-year decline in rail volumes for the week ending October 25, 2025, totaling 498,462 carloads and intermodal units moved, despite a 2% year-to-date increase [1] - North American rail volumes, including major U.S. players, averaged around 700,000 carloads over the trailing four-week period, showing a year-over-year dip while intermodal traffic, which constitutes 53% of total volume, experienced a 4% year-to-date gain but fell 4% in Week 43 [2] Commodity Performance - Grain volumes have increased by 7% year-to-date and 5% quarter-to-date, driven by strong U.S. exports amid global supply disruptions, with record soybean harvests reported by the U.S. Department of Agriculture [3] - Coal shipments showed mixed results, remaining flat weekly but down 3% quarter-to-date and up 4% year-to-date, reflecting earlier increases in domestic power plant usage, although recent declines indicate a cooling trend as natural gas prices stabilize [3] Automotive Sector Impact - North American automotive carloads decreased by 10% in Week 43, with a quarter-to-date increase of 2%, primarily due to a fire at Novelis' aluminum plant, which halted production and is expected to cost Ford an estimated 90,000-100,000 vehicles in Q4 [4] - Ford is increasing shifts at other plants to mitigate losses, while GM is facing lesser impacts; Eastern railroads anticipate Q4 pressure due to their proximity to affected auto plants, whereas Western railroads have maintained relative stability [4]
New CSX CEO switches up executive leadership
Yahoo Finance· 2025-10-29 12:43
Core Insights - CSX has undergone a leadership change with the appointment of Kevin Boone as Chief Financial Officer and Maryclare Kenney as Chief Commercial Officer, following the arrival of new CEO Steve Angel [1][2][4]. Leadership Changes - Kevin Boone, previously the executive vice president and chief commercial officer, has been appointed as the new chief financial officer, replacing Sean Pelkey, who has left the company [1][2]. - Maryclare Kenney has been promoted to senior vice president and chief commercial officer, having been a leader in CSX's commercial operations for nearly 14 years [1][3]. Executive Backgrounds - Kevin Boone joined CSX in 2017 and has held various leadership roles, including a previous two-year term as chief financial officer and vice president of corporate affairs and investor relations [2]. - Maryclare Kenney was responsible for merchandise sales and marketing, Transflo transload and logistics, automotive, and Total Distribution Services, Inc. (TDSI) prior to her promotion [3]. CEO's Vision - CEO Steve Angel expressed confidence in the new leadership team, stating they are well-positioned to build on CSX's momentum and achieve long-term success [2][4]. - Angel emphasized the importance of developing a strong talent pipeline and operational excellence within the railroad industry [4].
CSX Announces New Leadership Appointments
Globenewswire· 2025-10-29 12:30
Core Insights - CSX has announced executive leadership changes to enhance strategic focus and long-term growth objectives, appointing Kevin Boone as CFO and promoting Maryclare Kenney to CCO [1][2] Leadership Changes - Kevin Boone has been appointed as executive vice president and chief financial officer, succeeding Sean Pelkey, who has left the company [1][2] - Maryclare Kenney has been promoted to senior vice president and chief commercial officer, emphasizing the company's commitment to value creation [1][2] Leadership Background - Kevin Boone joined CSX in 2017 and has held various leadership roles, including executive vice president and chief commercial officer, and has experience in navigating supply chain challenges during the COVID-19 pandemic [3] - Maryclare Kenney has been with CSX for nearly 14 years, previously overseeing Merchandise Sales and Marketing, and has held leadership roles in intermodal and automotive sectors [4] Company Vision - The president and CEO of CSX expressed confidence in the new leaders, stating they will help build a high-performance culture and aim to make CSX the best-performing railroad in the nation [2][5] Company Overview - CSX is a premier transportation company based in Jacksonville, Florida, providing rail and intermodal services across various markets, contributing significantly to the U.S. economic expansion [6]
CSX Corporation: Benefiting From A Merger Environment (CSX)
Seeking Alpha· 2025-10-23 15:31
Core Insights - The article reflects on the author's extensive experience as an investor, highlighting the ability to navigate through significant market crashes in 1987, 2000, and 2008, indicating resilience and adaptability in investment strategies [1] Group 1 - The author has utilized trading systems developed with TradeStation, suggesting a reliance on technology and systematic approaches in trading [1] - The author has benefited from both buy-and-hold strategies and active trading, indicating a diversified investment approach [1] - The professional background includes several decades as a process control engineer, which may contribute to analytical skills in investment decision-making [1] Group 2 - There is no disclosure of any stock, option, or similar derivative positions in the companies mentioned, indicating a neutral stance in the analysis presented [2] - The article expresses personal opinions without compensation, suggesting independence in the analysis [2] - The author has no business relationships with any companies mentioned, reinforcing the objectivity of the insights provided [2]